BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1323022)

  • 1. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Contreras A; Maxwell A
    Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual mechanism for resistance to the antibiotic coumermycin A1.
    del Castillo I; Vizán JL; Rodríguez-Sáinz MC; Moreno F
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8860-4. PubMed ID: 1656457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
    Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG; Beckman DL; Foster-Hartnett D
    FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V; Urios A; Herrera G; Blanco M
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
    Samuels DS; Marconi RT; Huang WM; Garon CF
    J Bacteriol; 1994 May; 176(10):3072-5. PubMed ID: 8188609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
    Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.
    Battisti JM; Smitherman LS; Samuels DS; Minnick MF
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2906-13. PubMed ID: 9797224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
    Hardy CD; Cozzarelli NR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA supercoiling in Escherichia coli: genetic basis of a compensatory mutation in DNA gyrase.
    McEachern F; Fisher LM
    FEBS Lett; 1989 Aug; 253(1-2):67-70. PubMed ID: 2547660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachyspira (Serpulina) hyodysenteriae gyrB mutants and interstrain transfer of coumermycin A(1) resistance.
    Stanton TB; Matson EG; Humphrey SB
    Appl Environ Microbiol; 2001 May; 67(5):2037-43. PubMed ID: 11319078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
    Samuels DS; Mach KE; Garon CF
    J Bacteriol; 1994 Oct; 176(19):6045-9. PubMed ID: 7928965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone-like protein HU and bacterial DNA topology: suppression of an HU deficiency by gyrase mutations.
    Malik M; Bensaid A; Rouviere-Yaniv J; Drlica K
    J Mol Biol; 1996 Feb; 256(1):66-76. PubMed ID: 8609614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.